If you were Rachel's healthcare provider, what would you do? Provide a rationale for your response. Include the pathological processes associated with breast cancer.
According to Health Insurance Portability and Accountability Act (HIPPA), it means that I am incapable of locating and notifying Kristin that her sister Racheal has tested positive for the BRCA1 Genome. Because Racheal is not interested in having her sister Kristin know about her condition, it is my responsibility to ask Lisa whether she is ready to talk to Kristin as regards DNA testing. I am going to clarify to Racheal the significance of genomic testing for the BRCA1 and BRCA2 DNA, and how it is going to help Kristin receive preventive treatment if a test was done on her and turned out positive for one of the DNA factors. I am also going to emphasize the fact that breast cancer is one of the most hereditary diseases that might be tested genetically, which implies one might get diagnosed early if he or she has this disease, and can prevent further complications. Ultimately, as Rachel’s care provider, if I am incapable of convincing my patient concerning a terminal illness, I would be obliged to refer her to another physician, such as genomic expert.
Delegate your assignment to our experts and they will do the rest.
Include the pathological processes associated with breast cancer. What role does the BRCA1 gene contribute to managing the patient’s care? Describe and explain the role of the BRCA1 and breast cancer 2, early onset (BRCA2) gene in contribution as a risk factor for breast cancer
In many breast cancer cases, they tend to be prominent within the ductal epithelium and metastasize early. Breast cancers are considered as heterogenous ailments with multiple, molecular, biologic, phenotypic, and pathologic alterations. Various genomic and epigenetic pathways have the potential of developing into malevolence. Cancers are persistently developing. Typical breast tissues and breast cancers share myoepithelial cells, endothelial cells, macrophages, and engine control module molecules (EMC0, that have the potential for influencing most carcinogenesis. According to (McCance, & Huether, 2014) both BRCA1 and BRCA2 are comprised of the genetic factor repair that demonstrates proof of an individual suffering from cancer. Both of these DNA’s are commonly understood as the hereditary breast cancer. These DNAs comprise proteins that overwhelm tumors. One of these DNAs is modified, which results in the generation of tumors (BRCA1 and BRCA2). In the broadest sense, BRCA1 mutations are the cause of most of the hereditary breast and ovarian cancers. Clinicians and doctors must establish a patient’s risk for the BRCA1 genetic factor, so that they may have the patient hereditarily tested and referred to a genomics expert. However, the mutations are increases in people that have a family history of both breast and ovarian cancer.
Analyze the risk factors for breast cancer and possible interventions to preventive health management for women and men.
A family member who has cancer cells develop in various regions of the body. Some risks factors of breast cells are influenced by the following; having dense breasts, utilizing combination hormone therapy, family, sex, genetic mutations, old age, taking oral contraceptives, among others. Mammography screening is essential early detection that might establish breast cancer at a first stage once treatment is more successful and less expensive. All screening programs should comprise a tactic to follow up both men and women with a positive reading and referring them to clinical assessment. On the other hand, prophylactic surgery is a risk-alleviating operation where the tissue at risk for cancer development is extracted. For example, patients might have bilateral prophylactic cancer tissues which can be wholly prevented (Masi, Blackman, & Peek, 2007).
References
McCance, K. L., & Huether, S. E. (2014 ). Pathophysiology: The Biologic Basis for Diseases in Adults and Children. (7th ed) . St. Louis, MO: Elsevier Mosby.
Masi, C. M., Blackman, D. J., & Peek, M. E. (2007). “Interventions to Enhance Breast Cancer Screening, Diagnosis, and Treatment among Racial and Ethnic Minority Women.” Medical Care Research and Review , 64(5), pp. 195-242.
